APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Regorafenib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Regorafenib Industry Growth and Trends Forecast to 2032

Report ID 174032080123 December 202578 pages

Choose your research edition.

Industry ResearchRegorafenib Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Regorafenib Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Regorafenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Regorafenib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Regorafenib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Regorafenib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Regorafenib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Regorafenib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Regorafenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Regorafenib include Beacon Pharmaceuticals, Bayer Pharmaceuticals and Drug International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Regorafenib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Regorafenib market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Regorafenib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Regorafenib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Regorafenib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Regorafenib Market by Company

Beacon Pharmaceuticals

Bayer Pharmaceuticals

Drug International

Regorafenib Segment by Type

Bottled Packaging

Film Coated Packaging

Regorafenib Segment by Application

Advanced Hepatocellular Carcinoma

Advanced Gastrointestinal Stromal Tumours

Metastatic Colorectal Cancer

Others

Regorafenib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Regorafenib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Regorafenib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Regorafenib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Regorafenib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Regorafenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bottled Packaging Table 2. Major Company of Film Coated Packaging Table 3. Global Regorafenib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Regorafenib Sales by Type (2021-2026) & (k pcs) Table 5. Global Regorafenib Sales Market Share in Volume by Type (2021-2026) Table 6. Global Regorafenib Sales by Type (2021-2026) & (US$ Million) Table 7. Global Regorafenib Sales Market Share in Value by Type (2021-2026) Table 8. Global Regorafenib Price by Type (2021-2026) & (US$/pcs) Table 9. Global Regorafenib Sales by Type (2027-2032) & (k pcs) Table 10. Global Regorafenib Sales Market Share in Volume by Type (2027-2032) Table 11. Global Regorafenib Sales by Type (2027-2032) & (US$ Million) Table 12. Global Regorafenib Sales Market Share in Value by Type (2027-2032) Table 13. Global Regorafenib Price by Type (2027-2032) & (US$/pcs) Table 14. North America Regorafenib Sales by Type (2021-2026) & (k pcs) Table 15. North America Regorafenib Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Regorafenib Sales by Type (2021-2026) & (k pcs) Table 17. Europe Regorafenib Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Regorafenib Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Regorafenib Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Regorafenib Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Regorafenib Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Regorafenib Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Regorafenib Sales by Type (2021-2026) & (US$ Million) Table 24. Regorafenib Industry Trends Table 25. Regorafenib Industry Drivers Table 26. Regorafenib Industry Opportunities and Challenges Table 27. Regorafenib Industry Restraints Table 28. Global Regorafenib Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Regorafenib Revenue Market Share by Company (2021-2026) Table 30. Global Regorafenib Sales by Company (2021-2026) & (k pcs) Table 31. Global Regorafenib Sales Share by Company (2021-2026) Table 32. Global Regorafenib Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Regorafenib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Regorafenib Major Company Production Sites and Headquarters Table 35. Global Regorafenib Company, Product Type & Application Table 36. Global Regorafenib Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Regorafenib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Regorafenib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Regorafenib Sales by Region (2021-2026) & (k pcs) Table 41. Global Regorafenib Sales Market Share in Volume by Region (2021-2026) Table 42. Global Regorafenib Sales by Region (2021-2026) & (US$ Million) Table 43. Global Regorafenib Sales Market Share in Value by Region (2021-2026) Table 44. Global Regorafenib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Regorafenib Sales by Region (2027-2032) & (k pcs) Table 46. Global Regorafenib Sales Market Share in Volume by Region (2027-2032) Table 47. Global Regorafenib Sales by Region (2027-2032) & (US$ Million) Table 48. Global Regorafenib Sales Market Share in Value by Region (2027-2032) Table 49. Global Regorafenib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Regorafenib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Regorafenib Sales by Application (2021-2026) & (k pcs) Table 52. Global Regorafenib Sales Market Share in Volume by Application (2021-2026) Table 53. Global Regorafenib Sales by Application (2021-2026) & (US$ Million) Table 54. Global Regorafenib Sales Market Share in Value by Application (2021-2026) Table 55. Global Regorafenib Price by Application (2021-2026) & (US$/pcs) Table 56. Global Regorafenib Sales by Application (2027-2032) & (k pcs) Table 57. Global Regorafenib Sales Market Share in Volume by Application (2027-2032) Table 58. Global Regorafenib Sales by Application (2027-2032) & (US$ Million) Table 59. Global Regorafenib Sales Market Share in Value by Application (2027-2032) Table 60. Global Regorafenib Price by Application (2027-2032) & (US$/pcs) Table 61. North America Regorafenib Sales by Application (2021-2026) & (k pcs) Table 62. North America Regorafenib Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Regorafenib Sales by Application (2021-2026) & (k pcs) Table 64. Europe Regorafenib Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Regorafenib Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Regorafenib Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Regorafenib Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Regorafenib Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Regorafenib Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Regorafenib Sales by Application (2021-2026) & (US$ Million) Table 71. Beacon Pharmaceuticals Company Information Table 72. Beacon Pharmaceuticals Business Overview Table 73. Beacon Pharmaceuticals Regorafenib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Beacon Pharmaceuticals Regorafenib Product Portfolio Table 75. Beacon Pharmaceuticals Recent Development Table 76. Bayer Pharmaceuticals Company Information Table 77. Bayer Pharmaceuticals Business Overview Table 78. Bayer Pharmaceuticals Regorafenib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Bayer Pharmaceuticals Regorafenib Product Portfolio Table 80. Bayer Pharmaceuticals Recent Development Table 81. Drug International Company Information Table 82. Drug International Business Overview Table 83. Drug International Regorafenib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. Drug International Regorafenib Product Portfolio Table 85. Drug International Recent Development Table 86. North America Regorafenib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 87. North America Regorafenib Sales by Country (2021-2026) & (k pcs) Table 88. North America Regorafenib Sales Market Share by Country (2021-2026) Table 89. North America Regorafenib Sales Forecast by Country (2027-2032) & (k pcs) Table 90. North America Regorafenib Sales Market Share Forecast by Country (2027-2032) Table 91. North America Regorafenib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Regorafenib Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Regorafenib Market Share by Country (2021-2026) Table 94. North America Regorafenib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Regorafenib Market Share Forecast by Country (2027-2032) Table 96. Europe Regorafenib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 97. Europe Regorafenib Sales by Country (2021-2026) & (k pcs) Table 98. Europe Regorafenib Sales Market Share by Country (2021-2026) Table 99. Europe Regorafenib Sales Forecast by Country (2027-2032) & (k pcs) Table 100. Europe Regorafenib Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Regorafenib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Regorafenib Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Regorafenib Market Share by Country (2021-2026) Table 104. Europe Regorafenib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Regorafenib Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Regorafenib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Regorafenib Sales by Country (2021-2026) & (k pcs) Table 108. Asia-Pacific Regorafenib Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Regorafenib Sales Forecast by Country (2027-2032) & (k pcs) Table 110. Asia-Pacific Regorafenib Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Regorafenib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Regorafenib Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Regorafenib Market Share by Country (2021-2026) Table 114. Asia-Pacific Regorafenib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Regorafenib Market Share Forecast by Country (2027-2032) Table 116. Latin America Regorafenib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 117. Latin America Regorafenib Sales by Country (2021-2026) & (k pcs) Table 118. Latin America Regorafenib Sales Market Share by Country (2021-2026) Table 119. Latin America Regorafenib Sales Forecast by Country (2027-2032) & (k pcs) Table 120. Latin America Regorafenib Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Regorafenib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Regorafenib Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Regorafenib Market Share by Country (2021-2026) Table 124. Latin America Regorafenib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Regorafenib Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Regorafenib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Regorafenib Sales by Country (2021-2026) & (k pcs) Table 128. Middle East and Africa Regorafenib Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Regorafenib Sales Forecast by Country (2027-2032) & (k pcs) Table 130. Middle East and Africa Regorafenib Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Regorafenib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Regorafenib Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Regorafenib Market Share by Country (2021-2026) Table 134. Middle East and Africa Regorafenib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Regorafenib Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Regorafenib Distributors List Table 139. Regorafenib Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Regorafenib Image Figure 2. Global Regorafenib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Regorafenib Market Size (2021-2032) & (US$ Million) Figure 4. Global Regorafenib Sales (2021-2032) & (k pcs) Figure 5. Bottled Packaging Image Figure 6. Global Bottled Packaging Sales YoY Growth (2021-2032) & (k pcs) Figure 7. Film Coated Packaging Image Figure 8. Global Film Coated Packaging Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Regorafenib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Regorafenib Market Share by Type 2025 VS 2032 Figure 11. North America Regorafenib Sales Market Share in Volume by Type in 2025 Figure 12. North America Regorafenib Sales Market Share in Value by Type in 2025 Figure 13. Europe Regorafenib Sales Market Share in Volume by Type in 2025 Figure 14. Europe Regorafenib Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Regorafenib Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Regorafenib Sales Market Share in Value by Type in 2025 Figure 17. Latin America Regorafenib Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Regorafenib Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Regorafenib Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Regorafenib Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Regorafenib Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Advanced Hepatocellular Carcinoma Image Figure 24. Global Advanced Hepatocellular Carcinoma Sales YoY Growth (2021-2032) & (k pcs) Figure 25. Advanced Gastrointestinal Stromal Tumours Image Figure 26. Global Advanced Gastrointestinal Stromal Tumours Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Metastatic Colorectal Cancer Image Figure 28. Global Metastatic Colorectal Cancer Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Global Regorafenib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Regorafenib Market Share by Application 2025 VS 2032 Figure 33. North America Regorafenib Sales Market Share in Volume by Application in 2025 Figure 34. North America Regorafenib Sales Market Share in Value by Application in 2025 Figure 35. Europe Regorafenib Sales Market Share in Volume by Application in 2025 Figure 36. Europe Regorafenib Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Regorafenib Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Regorafenib Sales Market Share in Value by Application in 2025 Figure 39. Latin America Regorafenib Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Regorafenib Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Regorafenib Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Regorafenib Sales Market Share in Value by Application in 2025 Figure 43. North America Regorafenib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 44. North America Regorafenib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Regorafenib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Regorafenib Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Regorafenib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 48. Europe Regorafenib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Regorafenib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Regorafenib Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Regorafenib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. Asia-Pacific Regorafenib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Regorafenib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Regorafenib Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Regorafenib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Latin America Regorafenib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Regorafenib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Regorafenib Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Regorafenib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 60. Middle East and Africa Regorafenib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Regorafenib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Regorafenib Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Regorafenib Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Regorafenib Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Bottled Packaging
  • Film Coated Packaging
Applications
  • Advanced Hepatocellular Carcinoma
  • Advanced Gastrointestinal Stromal Tumours
  • Metastatic Colorectal Cancer
  • Others
Companies covered
  • Beacon Pharmaceuticals
  • Bayer Pharmaceuticals
  • Drug International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Regorafenib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Regorafenib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Regorafenib Market by Type
  6. 1.3.1 Bottled Packaging
  7. 1.3.2 Film Coated Packaging
  8. 1.4 Global Regorafenib Market Size by Type
  9. 1.4.1 Global Regorafenib Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Regorafenib Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Regorafenib Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Regorafenib Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Regorafenib Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Regorafenib Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Regorafenib Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Regorafenib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Regorafenib Industry Trends
  2. 2.2 Regorafenib Industry Drivers
  3. 2.3 Regorafenib Industry Opportunities and Challenges
  4. 2.4 Regorafenib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Regorafenib Revenue (2021-2026)
  2. 3.2 Global Top Players by Regorafenib Sales (2021-2026)
  3. 3.3 Global Top Players by Regorafenib Price (2021-2026)
  4. 3.4 Global Regorafenib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Regorafenib Major Company Production Sites & Headquarters
  6. 3.6 Global Regorafenib Company, Product Type & Application
  7. 3.7 Global Regorafenib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Regorafenib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Regorafenib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Regorafenib Tier 1, Tier 2, and Tier 3
4 Regorafenib Regional Status and Outlook
  1. 4.1 Global Regorafenib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Regorafenib Historic Market Size by Region
  3. 4.2.1 Global Regorafenib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Regorafenib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Regorafenib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Regorafenib Forecasted Market Size by Region
  7. 4.3.1 Global Regorafenib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Regorafenib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Regorafenib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Regorafenib by Application
  1. 5.1 Regorafenib Market by Application
  2. 5.1.1 Advanced Hepatocellular Carcinoma
  3. 5.1.2 Advanced Gastrointestinal Stromal Tumours
  4. 5.1.3 Metastatic Colorectal Cancer
  5. 5.1.4 Others
  6. 5.2 Global Regorafenib Market Size by Application
  7. 5.2.1 Global Regorafenib Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Regorafenib Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Regorafenib Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Regorafenib Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Regorafenib Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Regorafenib Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Regorafenib Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Regorafenib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Beacon Pharmaceuticals
  2. 6.1.1 Beacon Pharmaceuticals Company Information
  3. 6.1.2 Beacon Pharmaceuticals Business Overview
  4. 6.1.3 Beacon Pharmaceuticals Regorafenib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Beacon Pharmaceuticals Regorafenib Product Portfolio
  6. 6.1.5 Beacon Pharmaceuticals Recent Developments
  7. 6.2 Bayer Pharmaceuticals
  8. 6.2.1 Bayer Pharmaceuticals Company Information
  9. 6.2.2 Bayer Pharmaceuticals Business Overview
  10. 6.2.3 Bayer Pharmaceuticals Regorafenib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Pharmaceuticals Regorafenib Product Portfolio
  12. 6.2.5 Bayer Pharmaceuticals Recent Developments
  13. 6.3 Drug International
  14. 6.3.1 Drug International Company Information
  15. 6.3.2 Drug International Business Overview
  16. 6.3.3 Drug International Regorafenib Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Drug International Regorafenib Product Portfolio
  18. 6.3.5 Drug International Recent Developments
7 North America by Country
  1. 7.1 North America Regorafenib Sales by Country
  2. 7.1.1 North America Regorafenib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Regorafenib Sales by Country (2021-2026)
  4. 7.1.3 North America Regorafenib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Regorafenib Market Size by Country
  6. 7.2.1 North America Regorafenib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Regorafenib Market Size by Country (2021-2026)
  8. 7.2.3 North America Regorafenib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Regorafenib Sales by Country
  2. 8.1.1 Europe Regorafenib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Regorafenib Sales by Country (2021-2026)
  4. 8.1.3 Europe Regorafenib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Regorafenib Market Size by Country
  6. 8.2.1 Europe Regorafenib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Regorafenib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Regorafenib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Regorafenib Sales by Country
  2. 9.1.1 Asia-Pacific Regorafenib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Regorafenib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Regorafenib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Regorafenib Market Size by Country
  6. 9.2.1 Asia-Pacific Regorafenib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Regorafenib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Regorafenib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Regorafenib Sales by Country
  2. 10.1.1 South America Regorafenib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Regorafenib Sales by Country (2021-2026)
  4. 10.1.3 South America Regorafenib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Regorafenib Market Size by Country
  6. 10.2.1 South America Regorafenib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Regorafenib Market Size by Country (2021-2026)
  8. 10.2.3 South America Regorafenib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Regorafenib Sales by Country
  2. 11.1.1 Middle East and Africa Regorafenib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Regorafenib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Regorafenib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Regorafenib Market Size by Country
  6. 11.2.1 Middle East and Africa Regorafenib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Regorafenib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Regorafenib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Regorafenib Value Chain Analysis
  2. 12.1.1 Regorafenib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Regorafenib Production Mode & Process
  7. 12.2 Regorafenib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Regorafenib Distributors
  10. 12.2.3 Regorafenib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst